ABUS
Arbutus Biopharma CorpCompany with tickers: ABUS
CIK
1447028
CUSIP
03879J100
Shares Outstanding
197,537,710
13F Activity (30d)
109 filings
107 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-04-21 | McElhaugh Michael J. | Director | 246,886 | 2025-04-21 | Rockefeller Capital Management |
| 2025-04-15 | McElhaugh Michael J. | Director | 53,114 | 2025-04-15 | Rockefeller Capital Management |
| 2025-03-31 | Sofia Michael J. | Officer | 250,000 | 2025-03-31 | Fidelity Brokerage Services LLC |
| 2025-03-24 | Sofia Michael J. | Officer | 250,000 | 2025-03-24 | Fidelity Brokerage Services LLC |
| 2025-03-19 | Sofia Michael J. | Officer | 150,000 | 2025-03-19 | Fidelity Brokerage Services LLC |
| 2025-03-13 | Sofia Michael J. | Officer | 100,000 | 2025-03-13 | Fidelity Brokerage Services LLC |
| 2025-03-07 | Sofia Michael J. | Member of immediate family of any of the foregoing | 167,162 | 2025-03-07 | Fidelity Brokerage Services LLC |
| 2025-02-04 | Michael J. McElhaugh | Director and Officer | 23,790 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
| 2025-02-04 | Karen Sims | Officer | 19,348 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
| 2025-02-04 | David C. Hastings | Officer | 22,183 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
| 2025-02-04 | J. Christopher Naftzger | Officer | 11,333 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
Showing 1–11 of 11 filings